Heavy Chain Disease

Heavy chain diseases (HCD) are immunoproliferative disorders characterized by the production of monoclonal immunoglobulin molecules composed of deleted heavy chains devoid of light chains. Here is the latest research.

April 30, 2020

Heavy eye syndrome mimicking abducens nerve palsies

The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
Caberry W Yu, Jonathan A Micieli
January 18, 2020

Ion-Ion Proton Transfer and Parallel Ion Parking for the Analysis of Mixtures of Intact Proteins on a Modified Orbitrap Mass Analyzer

Journal of the American Society for Mass Spectrometry
Scott A UgrinDonald F Hunt
January 19, 2020
Case Report

Heavy eye syndrome precipitated by superotemporal Ahmed glaucoma valve implantation in a woman with axial high myopia

Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus
Arif O Khan, James Bacon
April 5, 2020
Review

Heavy Lifting: Nomenclature and Novel Therapy for Gamma Heavy Chain Disease and Other Heavy Chain Disorders

Clinical Lymphoma, Myeloma & Leukemia
Sara SingerAshley E Rosko
June 2, 2020

Exotropic heavy eye syndrome in unilateral high axial myopia

Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus
Ahmed Awadein, Dina H Hassanein
March 18, 2020
Preprint
Open Access

A single mechanism for global and selective response inhibition under the influence of motor preparation

BioRxiv : the Preprint Server for Biology
Liisa RaudIan Greenhouse
August 31, 2019

Mixed-trophies biofilm cultivation in capillary reactors

MethodsX
Ingeborg HeuschkelKatja Bühler
February 26, 2020

Inferior rectus displacement in heavy eye syndrome and sagging eye syndrome

Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie
Michael KinoriDavid B Granet
December 28, 2019
Open Access

Copy Number Variation of Transposable Elements in Thinopyrum intermedium and Its Diploid Relative Species

Plants
Mikhail G DivashukPavel Yu Kroupin
September 19, 2019

Immunohistochemical profile of renal cell tumours

Revista española de patología : publicación oficial de la Sociedad Española de Anatomía Patológica y de la Sociedad Española de Citología
Víctor Manuel Gutiérrez OlivaresMaria Camila Niebles De la Hoz
January 30, 2020
Open Access

Metabo groups in response to micronutrient intervention: Pilot study

Food Science & Nutrition
Carolina Almeida Coelho-LandellJacqueline Pontes Monteiro
December 31, 2019
Case Report

Identification of gamma heavy chain disease using MALDI-TOF mass spectrometry

Clinical Biochemistry
Katie L ThorenKazunori Murata
February 1, 2020
Open Access

Topological Linking Drives Anomalous Thickening of Ring Polymers in Weak Extensional Flows

Physical Review Letters
Thomas C O'ConnorGary S Grest
April 20, 2020

Alpha Frequency Intervention by Electrical Stimulation to Improve Performance in Mu-based BCI

IEEE Transactions on Neural Systems and Rehabilitation Engineering : a Publication of the IEEE Engineering in Medicine and Biology Society
Xiangzi ZhangJinyi Long
November 24, 2019

Site- and structure-specific quantitative N-glycoproteomics study of differential N-glycosylation in MCF-7 cancer cells

Journal of Proteomics
Bingbing XueZhixin Tian
February 5, 2020
Case Report

Gamma Heavy Chain Disease - Diagnostic Challenges in an Unusual Case and a Brief Synopsis of the Current Literature

Clinical Laboratory
Ingo Mrosewski, Matthias Urbank

Sign up to follow this feed and discover related papers.

Related Feeds

Antibodies: Agglutination

Antibody-mediated agglutination is the clumping of cells in the presence of antibody, which binds multiple cells together. This enhances the clearance of pathogens. Find the latest research on antibody-mediated agglutination here.

Antibodies: Complement Activation

The complement system can be activated by antigen-associated antibody. In the classical pathway of complement activation, C1q, C4b, and C3b are all able to bind to the Fc portion of IgG or IgM. Find the latest research on antibodies and complement activation here.

Antibody Development

Development of antibodies require integration of knowledge with respect to target antigen properties, antibody design criteria such as affinity, isotype selection, Fc domain engineering, and antibody cross-reactivity across species from the early stages of antibody development. Here is the latest research.


Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.

Antibody synthesis

Antibodies have various functions including neutralization of pathogens, tumor targeting, as well as its utility in biomedical research. Here is the latest research on antibody synthesis.

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.

Antibody-Dependent Enhancement

Antibody-dependent enhancement of viral infection is the entry of virus into host cells mediated by antiviral antibodies interacting with Fc or complement receptors. This has been most extensively observed with the dengue virus. Find the latest research on antibody-dependent enhancement here.

Antigenic Modulation

Antigenic modulation occurs when an antibody cross-links antigens on a cell surface, causing the antigens to become internalized. This can lead to therapeutic failure of monoclonal antibodies as the expression of the antigen becomes decreased on target cells. Find the latest research on antigenic modulation here.

B cell Activation

B cell activation is initiated by the ligation of the B cell receptor with antigen and ultimately results in the production of protective antibodies against potentially pathogenic invaders. Here is the latest research.

B cell Differentiation

Depending on the signal received through the B cell receptor and other receptors, B cells differentiate into follicular or marginal zone B cells. Here is the latest research pertaining to this differentiation process.

© 2020 Meta ULC. All rights reserved
/feed-previews/heavy-chain-disease/1f3ae842-d0a4-40d0-9646-1c8f26a3767c